Plasmablastic lymphoma and related disorders

American Journal of Clinical Pathology

Volumn 136, Issue 2, 2011, Pages 183-194

  Hsi, Eric D ^a   Lorsbach, Robert B ^b   Fend, Falko ^c   Dogan, Ahmet ^d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d MAYO CLINIC   (United States)

Author keywords

Anaplastic large cell lymphoma kinase; B cell lymphomas; Castleman disease; Diffuse large B cell lymphoma; HIV infection; Human herpesvirus 8; Plasmablastic lymphoma

Indexed keywords

B LYMPHOCYTE DIFFERENTIATION FACTOR; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD30 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN; INTERFERON REGULATORY FACTOR 4; KERATIN; SYNDECAN 1; X BOX BINDING PROTEIN 1;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; B CELL LYMPHOMA; B LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LARGE CELL LYMPHOMA; LYMPHOMA; MOLECULAR GENETICS; PLASMABLASTIC LYMPHOMA; PRIORITY JOURNAL;

HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; PLASMA CELLS;

EID: 79961016555     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPV1I2QWKZKNJH     Document Type: Conference Paper

References (27)

1. Tarte K, De Vos J, Thykjaer T, et al. Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts. Blood. 2002;100:1113-1122. (Pubitemid 34864260)
2. Tarte K, Zhan F, De Vos J, et al. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood. 2003;102:592-600. (Pubitemid 36841980)
3. Gaidano G, Cerri M, Capello D, et al. Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol. 2002;119:622-628. (Pubitemid 35366199)
4. Stein H, Harris NL, Campo E. Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:256-257.
5. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008;83:804-809.
6. Delecluse H, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413-1420. (Pubitemid 27080006)
7. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736-747. (Pubitemid 38685887)
8. Kim JE, Kim YA, Kim WY, et al. Human immunodeficiency virus-negative plasmablastic lymphoma in Korea. Leuk Lymphoma. 2009;50:582-587.
9. Teruya-Feldstein J, Chiao E, Filippa DA, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol. 2004;15:1673-1679. (Pubitemid 39562609)
10. Greipp PR, Leong T, Bennett JM, et al. Plasmablastic morphology: an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group. Blood. 1998;91:2501-2507. (Pubitemid 28155526)
11. Lin O, Frizzera G. Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases. Am J Surg Pathol. 1997;21:1295-1306. (Pubitemid 27460856)
12. Hall PA, Donaghy M, Cotter FE, et al. An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Histopathology. 1989;14:333-346, 429-432.
13. Radaszkiewicz T, Hansmann ML, Lennert K. Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant. Histopathology. 1989;14:11-24. (Pubitemid 19045804)
14. Dispenzieri A. POEMS syndrome. Blood Rev. 2007;21:285-299. (Pubitemid 47498680)
15. Lin BT, Weiss LM. Primary plasmacytoma of lymph nodes. Hum Pathol. 1997;28:1083-1090. (Pubitemid 27388111)
16. Schlosnagle DC, Chan WC, Hargreaves HK, et al. Plasmacytoma arising in giant lymph node hyperplasia. Am J Clin Pathol. 1982;78:541-544. (Pubitemid 12003574)
17. Boshoff C, Weiss RA. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci. 2001;356:517-534. (Pubitemid 32442750)
18. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995;86:1276-1280.
19. Chadburn A, Cesarman E, Nador RG, et al. Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus. Cancer. 1997;80:788-797. (Pubitemid 27339835)
20. Du MQ, Liu H, Diss TC, et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood. 2001;97:2130-2136. (Pubitemid 32239096)
21. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95:1406-1412. (Pubitemid 30099854)
22. Du M, Diss T, Liu H, et al. KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood. 2002;100:3415-3418. (Pubitemid 35217095)
23. Hernandez C, Cetner AS, Wiley EL. Cutaneous presentation of plasmablastic post-transplant lymphoproliferative disorder in a 14-month-old. Pediatr Dermatol. 2009;26:713-716.
24. Montes-Moreno S, Gonzalez-Medina AR, Rodriguez-Pinilla SM, et al. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica. 2010;95:1342-1349.
25. Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, et al. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod Pathol. 2010;23:991-999.
26. Valera A, Balague O, Colomo L, et al. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol. 2010;34:1686-1694.
27. Lorsbach RB, Hsi ED, Dogan A, et al. Plasma cell myeloma and related neoplasms. Am J Clin Pathol. 2011;136:168-182.